185 related articles for article (PubMed ID: 36095092)
41. Formation and analysis of tobacco-specific N-nitrosamines.
Brunnemann KD; Prokopczyk B; Djordjevic MV; Hoffmann D
Crit Rev Toxicol; 1996; 26(2):121-37. PubMed ID: 8688156
[TBL] [Abstract][Full Text] [Related]
42. [Measurement of Nicotine, Tobacco-Specific Nitrosamines, and Additives in the Filler and Gas from Japanese Brand Snuff].
Inaba Y; Utsugi R; Ohkubo T; Uchiyama S; Ohta T; Kunugita N
Nihon Eiseigaku Zasshi; 2016; 71(1):76-83. PubMed ID: 26832620
[TBL] [Abstract][Full Text] [Related]
43. Tobacco (kretek) smoking, betel quid chewing and risk of oral cancer in a selected Jakarta population.
Amtha R; Razak IA; Basuki B; Roeslan BO; Gautama W; Puwanto DJ; Ghani WM; Zain RB
Asian Pac J Cancer Prev; 2014; 15(20):8673-8. PubMed ID: 25374188
[TBL] [Abstract][Full Text] [Related]
44. Smokeless tobacco use among adult patients who visited family practice clinics in Karachi, Pakistan.
Ali NS; Khuwaja AK; Ali T; Hameed R
J Oral Pathol Med; 2009 May; 38(5):416-21. PubMed ID: 19434816
[TBL] [Abstract][Full Text] [Related]
45. A study of snuff carcinogenesis.
Brunnemann KD; Rivenson A; Adams JD; Hecht SS; Hoffmann D
IARC Sci Publ; 1987; (84):456-9. PubMed ID: 3679421
[TBL] [Abstract][Full Text] [Related]
46. Grass roots approach to control levels of carcinogenic nitrosamines, NNN and NNK in smokeless tobacco products.
Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
Food Chem Toxicol; 2019 Feb; 124():359-366. PubMed ID: 30543893
[TBL] [Abstract][Full Text] [Related]
47. N-nitrosamines in snuff and chewing tobacco on the Swedish market in 1983.
Osterdahl BG; Slorach S
Food Addit Contam; 1984; 1(4):299-305. PubMed ID: 6543619
[TBL] [Abstract][Full Text] [Related]
48. Risk for oral cancer from smokeless tobacco.
Janbaz KH; Qadir MI; Basser HT; Bokhari TH; Ahmad B
Contemp Oncol (Pozn); 2014; 18(3):160-4. PubMed ID: 25520574
[TBL] [Abstract][Full Text] [Related]
49. Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis.
Mu G; Wang J; Liu Z; Zhang H; Zhou S; Xiang Q; Cui Y
BMC Cancer; 2021 Aug; 21(1):960. PubMed ID: 34452595
[TBL] [Abstract][Full Text] [Related]
50. Arsenic content in smokeless tobacco products consumed by the population of Pakistan: related health risk.
Arain SS; Gul Kazi T; Afridi HI; Brahman KD; NaEemuliah ; Shah F; Mughal MA
J AOAC Int; 2014; 97(6):1662-9. PubMed ID: 25632442
[TBL] [Abstract][Full Text] [Related]
51. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan.
Idris AM; Nair J; Friesen M; Ohshima H; Brouet I; Faustman EM; Bartsch H
Carcinogenesis; 1992 Jun; 13(6):1001-5. PubMed ID: 1600602
[TBL] [Abstract][Full Text] [Related]
52. Shotgun metagenome sequencing of a Sudanese toombak snuff tobacco: genetic attributes of a high tobacco-specific nitrosamine containing smokeless tobacco product.
Tyx RE; Rivera AJ; Stanfill SB; Zaatari GS; Watson CH
Lett Appl Microbiol; 2022 Mar; 74(3):444-451. PubMed ID: 34862647
[TBL] [Abstract][Full Text] [Related]
53. Mutagenic activity in smokeless tobacco products sold in the USA.
Guttenplan JB
Carcinogenesis; 1987 May; 8(5):741-3. PubMed ID: 3581433
[TBL] [Abstract][Full Text] [Related]
54. Chewing areca nut, betel quid, oral snuff, cigarette smoking and the risk of oesophageal squamous-cell carcinoma in South Asians: a multicentre case-control study.
Akhtar S; Sheikh AA; Qureshi HU
Eur J Cancer; 2012 Mar; 48(5):655-61. PubMed ID: 21733677
[TBL] [Abstract][Full Text] [Related]
55. Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis.
Pedroso CM; Normando AGC; Siracusa CS; Lauby-Secretan B; Nethan ST; Tomasi RA; Lopes MA; Warnakulasuriya S; Santos-Silva AR
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Sep; 136(3):322-332. PubMed ID: 37076380
[TBL] [Abstract][Full Text] [Related]
56. Going Smokeless: Promotional Features and Reach of US Smokeless Tobacco Direct-Mail Advertising (July 2017-August 2018).
Czaplicki L; Rahman B; Simpson R; Rose SW; Liu M; Perks SN; Moran MB; Schillo BA
Nicotine Tob Res; 2021 Aug; 23(8):1349-1357. PubMed ID: 33270109
[TBL] [Abstract][Full Text] [Related]
57. Comparison of tobacco-specific nitrosamine levels in smokeless tobacco products: High levels in products from Bangladesh.
Nasrin S; Chen G; Watson CJW; Lazarus P
PLoS One; 2020; 15(5):e0233111. PubMed ID: 32453764
[TBL] [Abstract][Full Text] [Related]
58. High-Intensity Sweeteners in Alternative Tobacco Products.
Miao S; Beach ES; Sommer TJ; Zimmerman JB; Jordt SE
Nicotine Tob Res; 2016 Nov; 18(11):2169-2173. PubMed ID: 27217475
[TBL] [Abstract][Full Text] [Related]
59. Use of rodent data for cancer risk assessment of smokeless tobacco in the regulatory context.
Nilsson R
Regul Toxicol Pharmacol; 2017 Aug; 88():338-348. PubMed ID: 28625913
[TBL] [Abstract][Full Text] [Related]
60. Are There Betel Quid Mixtures Less Harmful than Others? A Scoping Review of the Association between Different Betel Quid Ingredients and the Risk of Oral Submucous Fibrosis.
Cirillo N; Duong PH; Er WT; Do CTN; De Silva MEH; Dong Y; Cheong SC; Sari EF; McCullough MJ; Zhang P; Prime SS
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
